Catalyst Wire Dossier Catalyst Wire Dossier

VIS954

· Visterra, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VIS954, covering 2025-07-14 to 2025-08-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954 [Phase 1]

See pricing